Citation Impact
Citing Papers
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema
2007
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Optical coherence tomography angiography
2017 Standout
Ranibizumab for the Treatment of Macular Edema Associated with Perfused Central Retinal Vein Occlusions
2008
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
2014
A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema
2011
Anti-vascular endothelial growth factor for diabetic macular oedema
2014
Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?
2012
A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
2011
Diabetic retinopathy
2010 Standout
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
Lasting Controversy on Ranibizumab and Bevacizumab
2011
Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies
2011
Complement, a target for therapy in inflammatory and degenerative diseases
2015
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
A review of clinical trials of anti-VEGF agents for diabetic retinopathy
2010
Proposed Lexicon for Anatomic Landmarks in Normal Posterior Segment Spectral-Domain Optical Coherence Tomography
2014 Standout
Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2
2014
Update on nonsurgical therapy for diabetic macular edema
2011
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
2015
Molecular pathogenesis of retinal and choroidal vascular diseases
2015
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
2016
Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy
2014
The role of inflammation in diabetic eye disease
2019
The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization
2016 StandoutNobel
Silicon Micro‐ and Nanofabrication for Medicine
2013
Diabetic Retinopathy
2012 Standout
Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema
2011
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Diabetic macular oedema
2016
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045
2021 Standout
Vascular endothelial growth factor in eye disease
2008 Standout
Microvascular Modifications in Diabetic Retinopathy
2011
CLINICAL CHARACTERISTICS OF ENDOPHTHALMITIS AFTER AN INJECTION OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
2010
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
2010
INTRAVITREAL BEVACIZUMAB PLUS GRID LASER PHOTOCOAGULATION OR INTRAVITREAL BEVACIZUMAB OR GRID LASER PHOTOCOAGULATION FOR DIFFUSE DIABETIC MACULAR EDEMA
2012
Endocrine side effects of cancer immunotherapy
2017
Age-related macular degeneration
2018 Standout
Pediatric Idiopathic Intracranial Hypertension
2007
Aging and vision
2010 Standout
Topical administration of a multi‐targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema
2008
Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
2017 Standout
Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
2014
The Relationship Between Axial Length and Choroidal Thickness in Eyes With High Myopia
2012
ULTRA-WIDEFIELD FUNDUS IMAGING
2016
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
2013
Ranibizumab for Diabetic Macular Edema
2012 Standout
Pediatric Idiopathic Intracranial Hypertension
2007
Etiology and Treatment of Macular Edema
2008
Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression
2016
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
2010 Standout
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
2011
Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
2011
Managing diabetic macular edema: The leading cause of diabetes blindness
2011
Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis
2016
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
2017
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: the SEVEN-UP Study
2015
Human Chorioretinal Layer Thicknesses Measured in Macula-wide, High-Resolution Histologic Sections
2011
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
2014
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
2016
Free-Standing Kinked Silicon Nanowires for Probing Inter- and Intracellular Force Dynamics
2015 StandoutNobel
Digoxin inhibits retinal ischemia‐induced HIF‐1α expression and ocular neovascularization
2010 StandoutNobel
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium*
2008
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
2018
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
REDEFINING MULTIFOCAL CHOROIDITIS AND PANUVEITIS AND PUNCTATE INNER CHOROIDOPATHY THROUGH MULTIMODAL IMAGING
2013
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis
2017
A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema
2008
Ocular and orbital side-effects of checkpoint inhibitors: a review article
2016
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
2017
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
2013 Standout
Prevalence of and Risk Factors for Diabetic Macular Edema in the United States
2014
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
2010
Functional Deficits Precede Structural Lesions in Mice With High-Fat Diet–Induced Diabetic Retinopathy
2016
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Emerging Pharmacotherapies for Diabetic Macular Edema
2012
Works of V. Diana being referenced
Trends for poorer vision outcomes in nAMD and DME patients with higher aqueous humor levels of IL-6
2019
Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography
2011
Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis
2013
Hospitalized cardiovascular events in patients with diabetic macular edema
2012
Ranibizumab for Edema of the Macula in Diabetes Study
2012
Antagonism of Vascular Endothelial Growth Factor for Macular Edema Caused by Retinal Vein Occlusions: Two-Year Outcomes
2010
MICROPERIMETRIC ASSESSMENT OF RETINAL SENSITIVITY IN EYES WITH DIABETIC MACULAR EDEMA FROM A PHASE 2 STUDY OF INTRAVITREAL AFLIBERCEPT
2015
One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema
2012
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
2009
Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema
2006
A PHASE IA DOSE-ESCALATION STUDY OF THE ANTI-FACTOR D MONOCLONAL ANTIBODY FRAGMENT FCFD4514S IN PATIENTS WITH GEOGRAPHIC ATROPHY
2013
Topical Mecamylamine for Diabetic Macular Edema
2010
Punctate Inner Choroidopathy
2007
A RANDOMIZED, DOUBLE-MASKED CONTROLLED CLINICAL TRIAL OF SANDOSTATIN LONG-ACTING RELEASE DEPOT IN PATIENTS WITH POSTSURGICAL CYSTOID MACULAR EDEMA
2010
Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion
2015
Panuveitis in Association with Pseudotumor Cerebri
2005
Ipilimumab-Associated Retinopathy
2015